New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Elanco Animal Health Incorporated
ELAN
Shape
US Flag

NYSE

6B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

6B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

12.97USD
Shape0.14 ( 1.09%)
favorite-chart

Relative Strenght

94
favorite-chart

Volume Buzz

0%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

31%

Quote Panel

Shape
Updated October 21, 2024
1W -7.03 % 1M -10.18 % 3M 1.33 % 1Y 42.53 %

Key Metrics

Shape
  • Market Cap

    6.41B


  • Shares Outstanding

    494.33M


  • Share in Float

    488.20M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    12.97


  • Average Volume

    4.80M


  • Beta

    1.402


  • Range

    8.52-18.8


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.elanco.com


  • Sector

    Healthcare


Fundamentals

Shape

14.41x

P/E Ratio

1.43x

P/S Ratio

1.08x

P/B Ratio

1.0

Debt/Equity

-27.9%

Net Margin

$-2.5

EPS

How ELAN compares to sector?

P/E Ratio

Relative Strength

Shape

ELAN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape285%

2025-Revenue

$0.17

Shape274%

2025-EPS

$831M

Shape200%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Overweight

2024-09-19

Now: Equal-Weight

Barclays

upgrade

Previous: Equal-Weight

2023-04-20

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

0.2
vs 0.19

Q4.22

arrow
arrow

-10%

0.19
vs 0.21

Q1.23

arrow
arrow

+25%

0.45
vs 0.36

Q2.23

arrow
arrow

-50%

0.18
vs 0.36

Q3.23

arrow
arrow

-10%

0.18
vs 0.2

Q4.23

arrow
arrow

-58%

0.08
vs 0.19

Q1.24

arrow
arrow

-24%

0.34
vs 0.45

Q2.24

arrow
arrow

+67%

0.3
vs 0.18

Q3.24

arrow
arrow

-32%

0.12
vs 0.18

Q4.24

arrow
arrow

+102%

0.16
vs 0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-9%

1B  vs 1.1B

Q4.22

arrow
arrow

-11%

988M  vs 1.1B

Q1.23

arrow
arrow

+3%

1.3B  vs 1.2B

Q2.23

arrow
arrow

-10%

1.1B  vs 1.2B

Q3.23

arrow
arrow

+4%

1.1B  vs 1B

Q4.23

arrow
arrow

+5%

1B  vs 988M

Q1.24

arrow
arrow

-4%

1.2B  vs 1.3B

Q2.24

arrow
arrow

+12%

1.2B  vs 1.1B

Q3.24

arrow
arrow

-3%

1B  vs 1.1B

Q4.24

arrow
arrow

-2%

1B  vs 1B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.00

Q4.22

arrow
arrow

-1%

-0.01
vs -0.01

Q1.23

arrow
arrow

+1%

0.01
vs -0.01

Q2.23

arrow
arrow

-1%

-0.01
vs 0.01

Q3.23

arrow
arrow

-18%

-0.18
vs -0.01

Q4.23

arrow
arrow

-2%

-0.02
vs -0.18

Q1.24

arrow
arrow

+1%

0.01
vs -0.02

Q2.24

arrow
arrow

-1%

-0.01
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

436

436
vs 447

-2%

Q4.22

arrow
arrow

428

428
vs 436

-2%

Q1.23

arrow
arrow

409

409
vs 428

-4%

Q2.23

arrow
arrow

370

370
vs 409

-10%

Q3.23

arrow
arrow

370

370
vs 370

NA

Q4.23

arrow
arrow

374

374
vs 370

1%

Q1.24

arrow
arrow

394

394
vs 374

5%

Q2.24

arrow
arrow

422

422
vs 394

7%

Earnings Growth

Latest News